Anteris Technologies Global Corp. (AVR)Healthcare | Medical Instruments & Supplies | Toowong, Australia | NasdaqGM
8.95 USD
-0.41
(-4.380%) ⇩
(July 14, 2026, 4 p.m.
EDT)
After hours: 8.95 |
Hot Take ↕ | July 11, 2026, 3:55 a.m. EDT
The investment case here is a stark dichotomy between a speculative price rally and a fundamentally broken business. On the surface, the stock has rallied roughly 162% over the past year, driven by a major strategic investment from Medtronic and a facility lease in Brooklyn Park. This catalyst has fueled a retail-driven mania, evidenced by the heavy call option flow targeting prices far above current levels. However, the underlying fundamentals tell a dire story: revenue has contracted by 11.2%, operating margins are catastrophic at nearly -49%, and the company is burning through cash with free cash flow of -$52 million. The balance sheet is technically clean due to low debt, but the inability to generate profit or cash flow suggests the Medtronic deal may be a lifeline rather than a transformation. With a forward P/E of negative infinity and no dividend to cushion the blow, the long-term outlook remains deeply bearish despite the short-term momentum. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.379083 |
| AutoARIMA | 0.389958 |
| AutoETS | 0.390212 |
| AutoTheta | 0.390249 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 27% |
| H-stat | 10.39 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.048 |
| Excess Kurtosis | -1.07 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.342 |
| Revenue per Share | 0.038 |
| Market Cap | 871,212,672 |
| Forward P/E | -9.13 |
| Beta | 0.73 |
| Previous Name | Anteris Technologies Ltd |
| Website | https://anteristech.com |
As of July 11, 2026, 3:55 a.m. EDT: Speculators are positioning aggressively for upside with heavy call volume and open interest at strikes above the current price, particularly in the August and November expirations. There is notable new flow into deep out-of-the-money calls ($17.5 strike in February), suggesting bets on a significant gap-up event. Conversely, put activity is minimal and concentrated at lower strikes, indicating limited hedging against downside compared to the bullish call positioning.
| Attribute | Value |
|---|---|
| 52 Week Change | 2.2275863 |
| Address1 | Toowong Tower |
| Address2 | Level 3, Suite 302 9 Sherwood Road |
| All Time High | 11.055 |
| All Time Low | 2.34 |
| Ask | 11.43 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 1,451,800 |
| Average Daily Volume3 Month | 1,192,545 |
| Average Volume | 1,192,545 |
| Average Volume10Days | 1,451,800 |
| Beta | 0.726 |
| Bid | 6.63 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 2.864 |
| City | Toowong |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | Australia |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 8.95 |
| Current Ratio | 20.934 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 9.45 |
| Day Low | 8.915 |
| Debt To Equity | 1.342 |
| Display Name | Anteris Technologies Global |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -94,434,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -6.271 |
| Enterprise To Revenue | 319.943 |
| Enterprise Value | 592,214,720 |
| Eps Current Year | -1.08 |
| Eps Forward | -0.98 |
| Eps Trailing Twelve Months | -2.12 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 8.7244 |
| Fifty Day Average Change | 0.22560024 |
| Fifty Day Average Change Percent | 0.02585854 |
| Fifty Two Week Change Percent | 222.75862 |
| Fifty Two Week High | 11.055 |
| Fifty Two Week High Change | -2.1050005 |
| Fifty Two Week High Change Percent | -0.19041161 |
| Fifty Two Week Low | 2.85 |
| Fifty Two Week Low Change | 6.1 |
| Fifty Two Week Low Change Percent | 2.1403508 |
| Fifty Two Week Range | 2.85 - 11.055 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,734,100,200,000 |
| Float Shares | 60,310,309 |
| Forward Eps | -0.98 |
| Forward P E | -9.132652 |
| Free Cashflow | -52,655,876 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 174 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.74284 |
| Gross Profits | 1,375,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.16469 |
| Held Percent Institutions | 0.66848 |
| Implied Shares Outstanding | 97,342,203 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ipo Expected Date | 2,024-12-13 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia. |
| Long Name | Anteris Technologies Global Corp. |
| Market | us_market |
| Market Cap | 871,212,672 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_24904237 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-14 |
| Net Income To Common | -95,304,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 911,123,020 |
| Number Of Analyst Opinions | 3 |
| Open | 9.36 |
| Operating Cashflow | -84,994,000 |
| Operating Margins | -48.597168 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 61 7 3152 3200 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 8.95 |
| Post Market Time | 1,784,059,804 |
| Prev Name | Anteris Technologies Ltd |
| Previous Close | 9.36 |
| Price Eps Current Year | -8.287037 |
| Price Hint | 2 |
| Price To Book | 3.1249998 |
| Price To Sales Trailing12 Months | 470.67136 |
| Profit Margins | 0.0 |
| Quick Ratio | 20.661 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.40999985 |
| Regular Market Change Percent | -4.3803406 |
| Regular Market Day High | 9.45 |
| Regular Market Day Low | 8.915 |
| Regular Market Day Range | 8.915 - 9.45 |
| Regular Market Open | 9.36 |
| Regular Market Previous Close | 9.36 |
| Regular Market Price | 8.95 |
| Regular Market Time | 1,784,059,200 |
| Regular Market Volume | 790,549 |
| Return On Assets | -0.33988 |
| Return On Equity | -0.59213 |
| Revenue Growth | -0.112 |
| Revenue Per Share | 0.038 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 97,342,203 |
| Shares Percent Shares Out | 0.063200004 |
| Shares Short | 6,150,188 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 5,416,565 |
| Short Name | Anteris Technologies Global Cor |
| Short Percent Of Float | 0.090299994 |
| Short Ratio | 4.16 |
| Source Interval | 15 |
| State | QLD |
| Symbol | AVR |
| Target High Price | 16.0 |
| Target Low Price | 15.0 |
| Target Mean Price | 15.33333 |
| Target Median Price | 15.0 |
| Total Cash | 282,699,008 |
| Total Cash Per Share | 2.904 |
| Total Debt | 3,735,000 |
| Total Revenue | 1,851,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.12 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.081825 |
| Two Hundred Day Average Change | 2.868175 |
| Two Hundred Day Average Change Percent | 0.47159776 |
| Type Disp | Equity |
| Volume | 790,549 |
| Website | https://anteristech.com |
| Zip | 4,066 |